Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference
February 16 2021 - 7:00AM
Sio Gene Therapies Inc. (NASDAQ: SIOX), a clinical-stage company
focused on developing gene therapies to radically improve the lives
of patients with neurodegenerative diseases, announced today that
the company will present at the 10th Annual SVB Leerink Global
Healthcare Conference taking place February 22-26, 2021. Details on
the presentation can be found below.
Date: |
Wednesday, February 24, 2021 |
Time: |
1:40 PM ET |
Participation
Format:Presenter: |
Fireside chatPavan Cheruvu, MD,
Chief Executive Officer |
Company management will also participate in one-on-one investor
meetings at the conference.
About Sio Gene Therapies
Sio Gene Therapies combines cutting-edge science with bold
imagination to develop genetic medicines that aim to radically
improve the lives of patients. Our current pipeline of
clinical-stage candidates includes the first potentially curative
AAV-based gene therapies for GM1 gangliosidosis and
Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal
pediatric conditions caused by single gene deficiencies. We are
also expanding the reach of gene therapy to highly prevalent
conditions such as Parkinson’s disease, which affects millions of
patients globally. Led by an experienced team of gene therapy
development experts, and supported by collaborations with premier
academic, industry and patient advocacy organizations, Sio is
focused on accelerating its candidates through clinical trials to
liberate patients with debilitating diseases through the
transformational power of gene therapies. For more information,
visit www.siogtx.com.
Contacts:
Media
Josephine Belluardo, Ph.D. LifeSci Communications(646)
751-4361jo@lifescicomms.cominfo@siogtx.com
Investors and Analysts
Parag V. Meswani, Pharm.D.Sio Gene Therapies Inc.Chief
Commercial Officerinvestors@siogtx.com
Sio Gene Therapies (NASDAQ:SIOX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sio Gene Therapies (NASDAQ:SIOX)
Historical Stock Chart
From Jul 2023 to Jul 2024